TABLE II. Recommended treatment for nicotine dependence. CBT, cognitive behavior therapy; FDA, US Food and Drug Administration; MAOI, Monoamine oxidase inhibitors; NicA, Nicotine Anonymous; NRT, nicotine replacement therapy; SR, sustained release.
Intervention | Details | Appraisal | Setting | Key references |
Integrated/combined treatment | Examples - Using a combined psychosocial and pharmacological approach - Treating tobacco-use disorder concurrently with other illnesses and psychiatric disorders - Concurrently pairing a long-acting NRT (ie, nicotine patch) with a short-acting NRT (ie, gum, lozenge, inhaler, or nasal spray) - Concurrently pairing a long-acting medication, such as varenicline or bupropion, with a rescue medication, such as the gum or lozenge |
- Integrated treatment delivers the best outcomes - Medications can complement each other, and combined psychosocial and pharmacological approaches can address both psychological and biological dependence |
Clinical | Lancaster et al,30 2000 Stead et al,31 2015 Stead et al,32 2016 |
Constituent treatments | ||||
Nicotine replacement therapies (NRT) | Five types: patch, gum, lozenge, inhaler, and nasal spray | - FDA-approved - Relatively low cost - Marginally less effective than Varenicline and Bupropion - Offer more steady delivery of nicotine than cigarettes, reducing reinforcement - Patch, gum, lozenge over-thecounter - Inhaler and nasal spray by prescription only in the United States |
Clinical; nonclinical | Lawrence et al,33 2009 |
Varenicline (Chantix) | Relieves craving and withdrawal, reducing the reinforcing effects of nicotine | - Most effective of the pharmacological interventions - FDA-approved - Be aware of black-box warning for cardiovascular adverse events - Be aware of possible neuropsychiatry symptoms in some patients (depressed mood, agitation, suicidality) |
Clinical | Lawrence et al,33 2009 |
Bupropion SR (Zyban) | An antidepressant that reduces cravings and other withdrawal effects | - Effective, but less so than Varenicline - FDA-approved - Do not use with seizure disorders, current use of bupropion, or MAOIs, electrolyte abnormalities, eating disorders |
Clinical | Lawrence et al,33 2009 |
Individual psychological intervention | Examples include brief counseling, motivational interviewing, cognitive behavior therapy | - Addresses psychological motivation to use tobacco and to quit - Even brief interventions have been shown to be effective |
Clinical | Stead et al,34 2013 Lindson-Hawley et al,35 2015 |
Group support | NicA, online support groups, CBT-based groups | - Leverages social support and social modeling in quitting - Aligns with other peer-support models for substance dependence - More effective than self-help, but not more effective than individual counseling |
Community, clinical, online | Steadt et al,36 2005 |
Mobile technologies | Text-message support, limited number of mobile apps | - Limited evidence for publicly available apps - Text-messaging support has been shown to be effective |
Community, online | Free et al,37 2011 Abroms et al38 2013 |
Organizational interventions | Smoke-free institutions, workplace counseling | - Provides environmental supports for quit attempts, reducing cues and increasing motivation - Effective when combined with individual interventions |
Community | Abroms et al,38 2013 |